Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2013

The following table shows our total share-based incentive compensation expense.


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2013		2012		2013		2012
Total share-based incentive compensation expense^{(1) (2)}	$	5.4	$	6.6	$	20.3	$	16.9

⁽¹⁾	The amounts included above do not include the expense related to our U.S. profit sharing contributions made in the form of our common stock or the expense or income related to SARS as such contributions are not considered share-based incentive compensation.

⁽²⁾

On February 28, 2013, the Organization and Compensation Committee of our Board of Directors (“O&C Committee”) approved a change in the vesting policy regarding the existing 2011 three-year PSU awards, and the newly granted 2013 three-year PSU awards, for William V. Hickey, our former Chairman and Chief Executive Officer. The approved change will result in the full vesting of the awards, rather than a pro-rata portion vesting as of the date of his retirement (May 16, 2013). Mr. Hickey’s awards will still be subject to the performance metrics stipulated in the plan documents, and will be paid-out in accordance with the original planned timing. As a result of these approved changes, the expense related to these awards was accelerated and recognized over the applicable service period up until the date of his retirement. We recognized share-based compensation expense related to these awards of $3 million in the nine months ended September 30, 2013.

Estimated Amount of Total Share-based Compensation Expense

The following table shows the estimated amount of total share-based incentive compensation expense expected to be recognized on a straight-line basis over the remaining respective vesting periods at September 30, 2013.


	2013		2014		2015		2016		Total
Total share-based incentive compensation expense ⁽¹⁾	$	8.4	$	16.6	$	11.2	$	3.4	$	39.6

⁽¹⁾	The amounts included above do not include the expense related to our U.S. profit sharing contributions made in the form of our common stock or the expense or income related to SARS as such contributions are not considered share-based incentive compensation.